Compare $SYBX vs $TPST | Chartloom

Compare

$SYBX vs $TPST

Synlogic Inc · Tempest Therapeutics Inc

SYBX

Synlogic Inc

TPST

Tempest Therapeutics Inc

Compare $SYBX vs $TPST

Comparing Synlogic Inc and Tempest Therapeutics Inc

SYBXSynlogic Inc

TPSTTempest Therapeutics Inc

SYBXSynlogic Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-6.0%

52W performance

-24.7%

FCF yield

-28.5%

TPSTTempest Therapeutics Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-6.3%

YTD performance

-74.2%

52W performance

-93.1%

FCF yield

-170.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SYBX

TPST

Detailed metrics comparison

SYBX

Synlogic Inc

TPST

Tempest Therapeutics Inc

Market Cap

SYBX$13M

TPST$12M

Enterprise Value

SYBX$292K

TPST$11M

Price

SYBX$1.10

TPST$0.76

P/E Ratio

SYBXN/A

TPSTN/A

P/S Ratio

SYBX4.20x

TPST45.67x

EV/Sales

SYBX0.09x

TPST43.07x

EV/EBITDA

SYBX0.00x

TPST0.00x

P/B Ratio

SYBX1.12x

TPST16.67x

P/FCF Ratio

SYBXN/A

TPSTN/A

EV/FCF

SYBX-0.08x

TPST-0.55x

PEG Ratio

SYBXN/A

TPSTN/A

Forward P/E (NTM)

SYBXN/A

TPSTN/A

Forward P/S (NTM)

SYBXN/A

TPSTN/A

Revenue (TTM)

SYBX$0

TPST$0

Revenue Growth (YoY)

SYBXN/A

TPST-6.3%

Forward Rev Growth

SYBX0.0%

TPST0.0%

Gross Margin (TTM)

SYBX0.0%

TPST0.0%

Operating Margin (TTM)

SYBX0.0%

TPST0.0%

EBITDA Margin (TTM)

SYBX0.0%

TPST0.0%

Net Margin (TTM)

SYBX0.0%

TPST0.0%

FCF Margin (TTM)

SYBXN/A

TPSTN/A

Net Income (TTM)

SYBX$-655K

TPST$-40M

FCF (TTM)

SYBX$-4M

TPST$-21M

EPS (TTM)

SYBX-$0.05

TPST-$2.66

ROE (TTM)

SYBX-560.0%

TPST-72989.0%

ROA (TTM)

SYBX-436.0%

TPST-29736.0%

ROIC (TTM)

SYBX-560.0%

TPST-72989.0%

Cash

SYBX$13M

TPST$779K

Debt

SYBX$0

TPST$0

Net Cash/Debt

SYBX$13M

TPST$779K

Current Ratio (TTM)

SYBX9.19x

TPST0.38x

Quick Ratio (TTM)

SYBX9.05x

TPST0.27x

Debt/Equity (TTM)

SYBX0.00x

TPST0.00x

Debt/Assets (TTM)

SYBX0.0%

TPST0.0%

Interest Coverage (TTM)

SYBXN/A

TPSTN/A

Net Debt/EBITDA (TTM)

SYBX0.00x

TPST0.00x

Beta

SYBX0.87

TPST-1.61

52W Performance

SYBX-24.7%

TPST-93.1%

YTD Performance

SYBX-6.0%

TPST-74.2%

% from 52W High

SYBX-41.2%

TPST-93.8%

% from 52W Low

SYBX103.7%

TPST2.3%

Asset Turnover (TTM)

SYBX0.05x

TPST0.01x

FCF Yield (TTM)

SYBX-28.5%

TPST-170.7%

Earnings Yield (TTM)

SYBX-4.9%

TPST-333.2%

Dividend Yield (TTM)

SYBXN/A

TPSTN/A

Rule of 40

SYBX0.0

TPST-6.3

EV/GP/RG

SYBXN/A

TPSTN/A

Ticker research

View SYBX research View TPST research

Metric	SYBX Synlogic Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$13M	$12M
Enterprise Value	$292K	$11M
Price	$1.10	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	4.20x	45.67x
EV/Sales	0.09x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.08x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-655K	$-40M
FCF (TTM)	$-4M	$-21M
EPS (TTM)	-$0.05	-$2.66
ROE (TTM)	-560.0%	-72989.0%
ROA (TTM)	-436.0%	-29736.0%
ROIC (TTM)	-560.0%	-72989.0%
Financial Health
Cash	$13M	$779K
Debt	$0	$0
Net Cash/Debt	$13M	$779K
Current Ratio (TTM)	9.19x	0.38x
Quick Ratio (TTM)	9.05x	0.27x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.87	-1.61
52W Performance	-24.7%	-93.1%
YTD Performance	-6.0%	-74.2%
% from 52W High	-41.2%	-93.8%
% from 52W Low	103.7%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.01x
FCF Yield (TTM)	-28.5%	-170.7%
Earnings Yield (TTM)	-4.9%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View SYBX research	View TPST research

Valuation

P/S Ratio

SYBX

4.20x

TPST

45.67x

EV/FCF

TPST

-0.55x

SYBX

-0.08x

Growth & revenue

Revenue Growth TTM

TPST

-6.3%

Forward Revenue Growth

SYBX

0.0%

TPST

0.0%

Profitability & performance

Gross Margin

SYBX

0.0%

TPST

0.0%

ROE

SYBX

-560.0%

TPST

-72989.0%

FCF Yield %

SYBX

-28.5%

TPST

-170.7%

52-Week Performance

SYBX

-24.7%

TPST

-93.1%

Detailed metrics comparison

SYBX

Synlogic Inc

TPST

Tempest Therapeutics Inc

Market Cap

SYBX$13M

TPST$12M

Enterprise Value

SYBX$292K

TPST$11M

Price

SYBX$1.10

TPST$0.76

P/E Ratio

SYBXN/A

TPSTN/A

P/S Ratio

SYBX4.20x

TPST45.67x

EV/Sales

SYBX0.09x

TPST43.07x

EV/EBITDA

SYBX0.00x

TPST0.00x

P/B Ratio

SYBX1.12x

TPST16.67x

P/FCF Ratio

SYBXN/A

TPSTN/A

EV/FCF

SYBX-0.08x

TPST-0.55x

PEG Ratio

SYBXN/A

TPSTN/A

Forward P/E (NTM)

SYBXN/A

TPSTN/A

Forward P/S (NTM)

SYBXN/A

TPSTN/A

Revenue (TTM)

SYBX$0

TPST$0

Revenue Growth (YoY)

SYBXN/A

TPST-6.3%

Forward Rev Growth

SYBX0.0%

TPST0.0%

Gross Margin (TTM)

SYBX0.0%

TPST0.0%

Operating Margin (TTM)

SYBX0.0%

TPST0.0%

EBITDA Margin (TTM)

SYBX0.0%

TPST0.0%

Net Margin (TTM)

SYBX0.0%

TPST0.0%

FCF Margin (TTM)

SYBXN/A

TPSTN/A

Net Income (TTM)

SYBX$-655K

TPST$-40M

FCF (TTM)

SYBX$-4M

TPST$-21M

EPS (TTM)

SYBX-$0.05

TPST-$2.66

ROE (TTM)

SYBX-560.0%

TPST-72989.0%

ROA (TTM)

SYBX-436.0%

TPST-29736.0%

ROIC (TTM)

SYBX-560.0%

TPST-72989.0%

Cash

SYBX$13M

TPST$779K

Debt

SYBX$0

TPST$0

Net Cash/Debt

SYBX$13M

TPST$779K

Current Ratio (TTM)

SYBX9.19x

TPST0.38x

Quick Ratio (TTM)

SYBX9.05x

TPST0.27x

Debt/Equity (TTM)

SYBX0.00x

TPST0.00x

Debt/Assets (TTM)

SYBX0.0%

TPST0.0%

Interest Coverage (TTM)

SYBXN/A

TPSTN/A

Net Debt/EBITDA (TTM)

SYBX0.00x

TPST0.00x

Beta

SYBX0.87

TPST-1.61

52W Performance

SYBX-24.7%

TPST-93.1%

YTD Performance

SYBX-6.0%

TPST-74.2%

% from 52W High

SYBX-41.2%

TPST-93.8%

% from 52W Low

SYBX103.7%

TPST2.3%

Asset Turnover (TTM)

SYBX0.05x

TPST0.01x

FCF Yield (TTM)

SYBX-28.5%

TPST-170.7%

Earnings Yield (TTM)

SYBX-4.9%

TPST-333.2%

Dividend Yield (TTM)

SYBXN/A

TPSTN/A

Rule of 40

SYBX0.0

TPST-6.3

EV/GP/RG

SYBXN/A

TPSTN/A

Ticker research

View SYBX research View TPST research

Metric	SYBX Synlogic Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$13M	$12M
Enterprise Value	$292K	$11M
Price	$1.10	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	4.20x	45.67x
EV/Sales	0.09x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.08x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-655K	$-40M
FCF (TTM)	$-4M	$-21M
EPS (TTM)	-$0.05	-$2.66
ROE (TTM)	-560.0%	-72989.0%
ROA (TTM)	-436.0%	-29736.0%
ROIC (TTM)	-560.0%	-72989.0%
Financial Health
Cash	$13M	$779K
Debt	$0	$0
Net Cash/Debt	$13M	$779K
Current Ratio (TTM)	9.19x	0.38x
Quick Ratio (TTM)	9.05x	0.27x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.87	-1.61
52W Performance	-24.7%	-93.1%
YTD Performance	-6.0%	-74.2%
% from 52W High	-41.2%	-93.8%
% from 52W Low	103.7%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.01x
FCF Yield (TTM)	-28.5%	-170.7%
Earnings Yield (TTM)	-4.9%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View SYBX research	View TPST research